Ruxolitinib for essential thrombocythemia?

Prithviraj Bose, Srdan Verstovsek

Research output: Contribution to journalEditorialpeer-review

3 Scopus citations
Original languageEnglish (US)
Pages (from-to)148-149
Number of pages2
JournalOncoscience
Volume4
Issue number11-12
DOIs
StatePublished - 2017

Keywords

  • Essential thrombocythemia
  • JAK inhibi-tor
  • Leukocyte count
  • Platelet count
  • Ruxolitinib
  • Symptoms

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this